These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17341557)

  • 21. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive.
    Archer DF; Nakajima ST; Sawyer AT; Wentworth J; Trupin S; Koltun WD; Gilbert RD; Ellman H
    Obstet Gynecol; 2013 Sep; 122(3):601-7. PubMed ID: 23921878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
    Poindexter AN; Burkman R; Fisher AC; LaGuardia KD
    Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB; Koontz SL; Nichols MD; Jensen JT
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals.
    Maier WE; Herman JR
    Regul Toxicol Pharmacol; 2001 Aug; 34(1):53-61. PubMed ID: 11502156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
    Phillips TJ; Symons J; Menon S;
    J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of orally administered norethisterone enanthate in rabbit, monkey, and women.
    Ravinder P; Shatrugna V; Nair KM; Sivakumar B
    Contraception; 1997 Jun; 55(6):373-9. PubMed ID: 9262934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoassay of norethindrone (17 alpha-ethynyl-17 beta-hydroxy-4-estren-3-one) and ethynyl-estradiol (17 alpha-ethynyl-1,3,5, (10)-estratien-3, 17 beta-diol). Application to human plasma determination of norethindrone after oral administration of this steroid.
    Pasqualini JR; Castellet R; Portois MC; Hill JL; Kincl FA; Cortes-Prieto J
    Reproduccion; 1975; 2(3-4):197-205. PubMed ID: 1232004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE).
    de Visser SJ; Uchida N; van Vliet-Daskalopoulou E; Fukazawa I; van Doorn MB; van den Heuvel MW; Machielsen CS; Uchida E; Cohen AF
    Contraception; 2003 Sep; 68(3):195-202. PubMed ID: 14561540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacodynamics of synthetic estrogens. Review article].
    Sojo-Aranda I; Cortés-Gallegos V
    Ginecol Obstet Mex; 1990 Oct; 58():277-83. PubMed ID: 2292429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate.
    Terlinden R; Uragg H; Göhler K; Kneip C
    Contraception; 2006 Sep; 74(3):239-44. PubMed ID: 16904418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissolution testing of norethindrone:ethinyl estradiol, norethindrone:mestranol, and norethindrone acetate:ethinyl estradiol combination tablets.
    Nguyen HT; Shiu GK; Worsley WN; Skelly JP
    J Pharm Sci; 1990 Feb; 79(2):163-7. PubMed ID: 2324966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aromatization of norethindrone to ethinyl estradiol by human placental microsomes.
    Barbieri RL; Petro Z; Canick JA; Ryan KJ
    J Clin Endocrinol Metab; 1983 Aug; 57(2):299-303. PubMed ID: 6863477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women.
    Atrio J; Stanczyk FZ; Neely M; Cherala G; Kovacs A; Mishell DR
    J Acquir Immune Defic Syndr; 2014 Jan; 65(1):72-7. PubMed ID: 24025339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norethindrone acetate (NA) and ethinyl estradiol (EE) related oxidative transformation products in stability samples of formulated drug product: synthesis of authentic references.
    Ekhato IV; Hurley T; Lovdahl M; Revitte TJ; Guo L; Huang Y; Clipper S; Colson C
    Steroids; 2002 Mar; 67(3-4):165-74. PubMed ID: 11856540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of 7 alpha-methyl-ethinyl estradiol during treatment with tibolone.
    Wiegratz I; Sänger N; Kuhl H
    Menopause; 2002; 9(4):293-5. PubMed ID: 12082366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of interaction of a low-dose combination oral contraceptive with anti-tubercular drugs.
    Joshi JV; Joshi UM; Sankolli GM; Gupta K; Rao AP; Hazari K; Sheth UK; Saxena BN
    Contraception; 1980 Jun; 21(6):617-29. PubMed ID: 7428368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations of ethynyl oestradiol and norethindrone after oral administration to women.
    Pasqualini JR; Castellet R; Portois MC; Hill JL; Kincl FA
    J Reprod Fertil; 1977 Mar; 49(2):189-93. PubMed ID: 850209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.